Evidence map›Paper›PMID 28203606›Full record

ArticleNeurogenesis (Austin, Tex.)2017

DNA methylation in oligodendroglial cells during developmental myelination and in disease.

Sarah Moyon, Patrizia Casaccia

Open access · diamondAbstract read
In one paragraph

Article in Neurogenesis (Austin, Tex.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. N6-methyladenosine and Neurological Diseases.Molecular neurobiology · 2022
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. mNeuron · 2020
    Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sarah MoyonDepartment of Neuroscience, Icahn School of Medicine at Mount Sinai , New York, NY, USA.
Patrizia CasacciaDepartment of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Neuroscience Initiative Advanced Science Research Center, CUNY, New York, NY, USA.
Icahn School of Medicine at Mount Sinai · US

Funding

Role of cell cycle regulators in differentiationR01NS052738 · NINDS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI CANOLL, PETER, CASACCIA, PATRIZIA · 2007 to 2020
$4.6M
NINDS NIH HHS R01 NS052738
6 · The paper itself

Abstract

Oligodendrocyte progenitor cells (OPC) are the myelinating cells of the central nervous system (CNS). During development, they differentiate into mature oligodendrocytes (OL) and ensheath axons, providing trophic and functional support to the neurons. This process is regulated by the dynamic expression of specific transcription factors, which, in turn, is controlled by epigenetic marks such as DNA methylation. Here we discuss recent findings showing that DNA methylation levels are differentially regulated in the oligodendrocyte lineage during developmental myelination, affecting both genes expression and alternative splicing events. Based on the phenotypic characterization of mice with genetic ablation of DNA methyltransferase 1 (

Indexed as

alternative splicingcell cycle exitDNA methylationgliomasmultiple sclerosismyelinationoligodendrocyte progenitor cellsoligodendrocytesremyelination

Identifiers

PMID28203606
PMCPMC5293321
OpenAlexW2583805516

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.